TÌNH HÌNH SỬ DỤNG CÁC CHẾ PHẨM MÁU TẠI BỆNH VIỆN NGUYỄN TRI PHƯƠNG GIAI ĐOẠN 2021-2023

Abstract

Objectives: Survey on the situation of blood blood component transfusion at Nguyen Tri Phuong hospital and the supply situation of blood products from suppliers to the hospital during the period 2021-2023. Subjects and methods: Cross-Sectional. All blood products transfused at Nguyen Tri Phuong hospital from January 2021 to December 2023. The data were collected from the blood dispensing records of the Laboratory department and presented using descriptive statistics. Results: From 2021 to 2023, a total of 26,315 units of blood products were used, primarily consisting of red blood cells (67.6%), fresh frozen plasma (26.8%), plateletpheresis (5.2%), and cryoprecipitate (0.5%). The departments that used the most blood products were Internal Medicine Department(40.7%), Intensive Care Unit (22.6%), Surgery Department (21.2%), and Emergency Department (8.4%). Blood group O was the most frequently used (44.5%), followed by blood groups B, A, and AB at 29.3%, 21.3%, and 4.8% respectively. The supply capability from the blood supply centers met or exceeded 95.6%. Conclusions: The situation of blood product trasfused in hospital is increasing during the period 2021-2023, the difference in the rate of blood products use reflects differences in the needs and treatment characteristics of patients in clinical departments, the ability to provide blood products from the supplier meets the hospital's needs very well